This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Sanofi Pasteur Inc.. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Diana Coronel: Innovator in Dengue Vaccination
Introduction
Diana Coronel is a prominent inventor based in Mexico City, MX. She has made significant contributions to the field of vaccine development, particularly in the fight against dengue fever. Her innovative work has led to the creation of a unique vaccine composition aimed at enhancing the immune response in individuals previously vaccinated against dengue.
Latest Patents
Diana Coronel holds a patent for her invention titled "Compositions for booster vaccination against dengue." This invention focuses on a method of booster vaccination and a vaccine composition designed to induce a neutralizing antibody response in human subjects. The composition includes a dengue antigen from at least one of the serotypes 1 to 4 or a nucleic acid construct capable of expressing these antigens. The booster vaccination aims to achieve a two-fold increase in the neutralizing antibody titre against each of the dengue serotypes.
Career Highlights
Diana Coronel is associated with Sanofi Pasteur Inc., a leading company in vaccine development. Her work has been instrumental in advancing the understanding and treatment of dengue fever through innovative vaccination strategies. With her expertise, she has contributed to the development of effective solutions to combat this viral disease.
Collaborations
Diana collaborates with notable colleagues such as Fernando Noriega and Yves Girerd-Chambaz. Their combined efforts in research and development have furthered the progress in vaccine technology and public health.
Conclusion
Diana Coronel's contributions to vaccine innovation, particularly in dengue vaccination, highlight her role as a key figure in the field. Her patent and collaborative efforts reflect her commitment to improving global health through scientific advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
